Opinion
3don MSNOpinion
The use of AI in biotechnology is changing faster than the rules governing either technology
The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance. But it also raised urgent ...
Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing ...
AI as defined by the UK Intellectual Property Office (‘UK IPO’) and European Patent Office (‘EPO’) Applications of AI in biotechnology How biotechnology companies can leverage AI to drive innovation ...
The Business & Financial Times on MSN
Financial security (FinSec) series with Dr Philip Takyi: NASDAQ 2026: The dawn of a new capital markets era as technology, biotechnology and quantum innovation redefine Wall Street
Please keep comments respectful. Use plain English for our global readership and avoid using phrasing that could be misinterpreted as offensive. By commenting, you agree to abide by our community ...
Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...
Masato Iida of Shiga International Patent Office explains how the inventive step obstacle can be cleared when preparing a patent application and presents several case studies based on combination ...
Dr. Ko-Cheng Fang, Founder, Chairman, and CEO of LongServing Technology Co., Ltd. in Taipei, Taiwan, represents a rare kind of modern innovator: one whose work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results